Using Combination Therapy to Thwart Drug Resistance
Abstract
Drug combination therapy is a promising strategy to extend the lifespan of our antimicrobials. Drug combinations used in treatment must be carefully selected to minimize the evolution of resistance, either by carefully determining drug pairs that hinder the acquisition of resistance mechanisms, or by screening for combinations that inhibit growth and show reduced vulnerability to resistance. Modeling of interactions between drugs has provided intriguing insights into strategies for combination therapy deployment. Ultimately, more rigorous clinical trials need to be performed to evaluate the laboratory and modeling results and advance treatment options.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Combination therapy has proven to be an effective approach in overcoming antifungal drug resistance.
“Combination therapy has proven to be an effective approach in overcoming antifungal drug resistance, significantly contributing to preserving the existing arsenal of antimicrobial agents, reducing treatment duration, and mitigating drug toxicity [18].”
From Lansoprazole interferes with fungal respiration and acts synergistically with amphotericin B against multidrug-resistant <i>Candida auris</i> (2024) · cites this paper as [18]
Cites
Antibiotic resistance and its cost: is it possible to reverse resistance?
Andersson, D. I., & Hughes, D. (2010) · Nature Reviews Microbiology · doi:10.1038/nrmicro2319 · Cited by 2,302 · see citing works
Antibiotics and Antibiotic Resistance Genes in Natural Environments
Martínez, J. L. (2008) · Science · doi:10.1126/science.1159483 · Cited by 1,802 · see citing works
Sampling the Antibiotic Resistome
D'Costa, V. M., McGrann, K. M., Hughes, D. W., & Wright, G. D. (2006) · Science · doi:10.1126/science.1120800 · Cited by 1,594 · see citing works
Humans as the World's Greatest Evolutionary Force
Palumbi, S. R. (2001) · Science · doi:10.1126/science.293.5536.1786 · Cited by 1,290 · see citing works
General Principles of Antimicrobial Therapy
Leekha, S., Terrell, C. L., & Edson, R. S. (2011) · Mayo Clinic Proceedings · doi:10.4065/mcp.2010.0639 · Cited by 902 · see citing works
Epidemiology of Invasive Mycoses in North America
Pfaller, M. A., & Diekema, D. J. (2010) · Critical Reviews in Microbiology · doi:10.3109/10408410903241444 · Cited by 901 · see citing works
Hsp90 Potentiates the Rapid Evolution of New Traits: Drug Resistance in Diverse Fungi
Cowen, L. E., & Lindquist, S. (2005) · Science · doi:10.1126/science.1118370 · Cited by 698 · see citing works
Self-citationActivated ClpP kills persisters and eradicates a chronic biofilm infection
Conlon, B. P., Nakayasu, E. S., Fleck, L. E., LaFleur, M. D., Isabella, V. M., Coleman, K., Leonard, S. N., Smith, R. D., Adkins, J., & Lewis, K. (2013) · Nature · doi:10.1038/nature12790 · Cited by 675 · see citing works
Systems biology and combination therapy in the quest for clinical efficacy
Fitzgerald, J. B., Schoeberl, B., Nielsen, U. B., & Sorger, P. K. (2006) · Nature Chemical Biology · doi:10.1038/nchembio817 · Cited by 570 · see citing works
Artemisinin-based combination therapies: a vital tool in efforts to eliminate malaria
Eastman, R. T., & Fidock, D. A. (2009) · Nature Reviews Microbiology · doi:10.1038/nrmicro2239 · Cited by 569 · see citing works
Evaluating treatment protocols to prevent antibiotic resistance
Bonhoeffer, S., Lipsitch, M., & Levin, B. R. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.22.12106 · Cited by 517 · see citing works
Multiple populations of artemisinin-resistant Plasmodium falciparum in Cambodia
Miotto, O., Garcia, J. A., Manske, M., MacInnis, B. L., Campino, S. G., Rockett, K. A., Amaratunga, C., Lim, P., Suon, S., Sreng, S., et al. (2013) · Nature Genetics · doi:10.1038/ng.2624 · Cited by 452 · see citing works
The mutant selection window and antimicrobial resistance
Drlica, K. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg269 · Cited by 440 · see citing works
Antibiotic interactions that select against resistance
Chait, R., Craney, A., & Kishony, R. (2007) · Nature · doi:10.1038/nature05685 · Cited by 439 · see citing works
Lack of development of new antimicrobial drugs: a potential serious threat to public health
Norrby, S. R., Nord, C. E., & Finch, R. (2005) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(05)01283-1 · Cited by 424 · see citing works
Functional classification of drugs by properties of their pairwise interactions
Yeh, P. J., Tschumi, A. I., & Kishony, R. (2006) · Nature Genetics · doi:10.1038/ng1755 · Cited by 350 · see citing works
Drug interactions and the evolution of antibiotic resistance
Yeh, P. J., Hegreness, M. J., Aiden, A. P., & Kishony, R. (2009) · Nature Reviews Microbiology · doi:10.1038/nrmicro2133 · Cited by 350 · see citing works
Accelerated evolution of resistance in multidrug environments
Hegreness, M., Shoresh, N., Damian, D., Hartl, D., & Kishony, R. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0805965105 · Cited by 300 · see citing works
Lack of development of new antimicrobial drugs: a potential serious threat to public health
Norrby, S. R., NORD, C., & Finch, R. (2005) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(05)70086-4 · Cited by 296 · see citing works
Peña‐Miller, R., Laehnemann, D., Jansen, G., Fuentes-Hernández, A., Rosenstiel, P. C., Hinrich Schulenburg, Y., & Beardmore, R. (2013) · PLoS Biology · doi:10.1371/journal.pbio.1001540 · Cited by 210 · see citing works
Cross‐species discovery of syncretic drug combinations that potentiate the antifungal fluconazole
Spitzer, M., Griffiths, E., Blakely, K. M., Wildenhain, J., Ejim, L., Rossi, L., De Pascale, G., Curak, J., Brown, E., Tyers, M., et al. (2011) · Molecular Systems Biology · doi:10.1038/msb.2011.31 · Cited by 183 · see citing works
Lehár, J., Stockwell, B. R., Giaever, G., & Nislow, C. (2008) · Nature Chemical Biology · doi:10.1038/nchembio.120 · Cited by 172 · see citing works
Optimal Drug Synergy in Antimicrobial Treatments
Torella, J. P., Chait, R., & Kishony, R. (2010) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1000796 · Cited by 164 · see citing works
Genetic and Genomic Architecture of the Evolution of Resistance to Antifungal Drug Combinations
Hill, J. A., Ammar, R., Torti, D., Nislow, C., & Cowen, L. E. (2013) · PLoS Genetics · doi:10.1371/journal.pgen.1003390 · Cited by 93 · see citing works
Self-citationThe fungal Achilles’ heel: targeting Hsp90 to cripple fungal pathogens
Cowen, L. E. (2013) · Current Opinion in Microbiology · doi:10.1016/j.mib.2013.03.005 · Cited by 93 · see citing works
Self-citationCombination antifungal therapy: a critical review of the evidence
Ostrosky‐Zeichner, L. (2008) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2008.01983.x · Cited by 59 · see citing works
Advancing the development of tuberculosis therapy
Zumla, A. I., Hafner, R., Lienhardt, C., Höelscher, M., & Nunn, A. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3694 · Cited by 58 · see citing works
Twenty-Five Years of Translational Medicine in Antiretroviral Therapy: Promises to Keep
Broder, S. E. (2010) · Science Translational Medicine · doi:10.1126/scitranslmed.3000749 · Cited by 23 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Molecular Evolution of Antifungal Drug Resistance
Robbins, N., Caplan, T., & Cowen, L. E. (2017) · Annual Review of Microbiology · doi:10.1146/annurev-micro-030117-020345 · Cited by 441 · see citing works
Self-citationAntifungal Drugs: The Current Armamentarium and Development of New Agents
Robbins, N., Wright, G. D., & Cowen, L. E. (2016) · Microbiology Spectrum · doi:10.1128/microbiolspec.funk-0002-2016 · Cited by 271 · see citing works
Self-citationImmune defence to invasive fungal infections: A comprehensive review
Pathakumari, B., Liang, G., & Liu, W. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110550 · Cited by 272 · see citing works
Combinatorial strategies for combating invasive fungal infections
Spitzer, M., Robbins, N., & Wright, G. D. (2016) · Virulence · doi:10.1080/21505594.2016.1196300 · Cited by 218 · see citing works
Geddes‐McAlister, J., & Shapiro, R. S. (2018) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.13739 · Cited by 159 · see citing works
Dijck, P. V., Sjollema, J., Cammue, B. P. A., Lagrou, K., Berman, J. G., d’Enfert, C., Andes, D. R., Arendrup, M. C., Brakhage, A. A., Calderone, R., et al. (2018) · Microbial Cell · doi:10.15698/mic2018.07.638 · Cited by 129 · see citing works
Self-citationBiological challenges of phage therapy and proposed solutions: a literature review
Caflisch, K. M., Suh, G. A., & Patel, R. (2019) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2019.1694905 · Cited by 108 · see citing works
Cyclodextrins in drug delivery: applications in gene and combination therapy
Haley, R. M., Gottardi, R., Langer, R., & Mitchell, M. J. (2020) · Drug Delivery and Translational Research · doi:10.1007/s13346-020-00724-5 · Cited by 109 · see citing works
Development and research progress of anti-drug resistant fungal drugs
Cui, X., Wang, L., Lü, Y., & Yue, C. (2022) · Journal of Infection and Public Health · doi:10.1016/j.jiph.2022.08.004 · Cited by 85 · see citing works
Phytotherapy as an alternative to conventional antimicrobials: combating microbial resistance
Enioutina, E. Y., Teng, L., Fateeva, T. V., Brown, J. C. S., Job, K. M., Бортникова, В. В., Krepkova, L. V., Gubarev, M. I., & Sherwin, C. M. T. (2017) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2017.1371591 · Cited by 78 · see citing works
Phytochemicals with activity against methicillin-resistant Staphylococcus aureus
Liang, M., Ge, X., Xua, H., Ma, K., Zhang, W., Zan, Y., Efferth, T., Xue, Z., & Hua, X. (2022) · Phytomedicine · doi:10.1016/j.phymed.2022.154073 · Cited by 67 · see citing works
Wambaugh, M. A., Shakya, V. P. S., Lewis, A. J., Mulvey, M. A., & Brown, J. C. S. (2017) · PLOS Biology · doi:10.1371/journal.pbio.2001644 · Cited by 63 · see citing works
Novel Strategies to Combat the Emerging Drug Resistance in Human Pathogenic Microbes
Qadri, H., Shah, A. H., & Mir, M. A. (2020) · Current Drug Targets · doi:10.2174/1389450121666201228123212 · Cited by 64 · see citing works
Li, Z., Tu, J., Han, G., Liu, N., & Sheng, C. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c01763 · Cited by 60 · see citing works
Shivarathri, R., Tscherner, M., Zwolanek, F., Singh, N. K., Chauhan, N., & Kuchler, K. (2019) · Scientific Reports · doi:10.1038/s41598-019-45817-5 · Cited by 58 · see citing works
Li, C., Tu, J., Han, G., Liu, N., & Sheng, C. (2021) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2021.113961 · Cited by 60 · see citing works
Potential Strategies to Control the Risk of Antifungal Resistance in Humans: A Comprehensive Review
Rabaan, A. A., Sulaiman, T., Al-Ahmed, S. H., Buhaliqah, Z. A., Buhaliqah, A. A., AlYuosof, B., Alfaresi, M. S., Fares, M. A. A., Alwarthan, S. M., Alkathlan, M. S., et al. (2023) · Antibiotics · doi:10.3390/antibiotics12030608 · Cited by 53 · see citing works
Bicyclic Boronate β‐Lactamase Inhibitors: The Present Hope against Deadly Bacterial Pathogens
Lence, E., & González‐Bello, C. (2021) · Advanced Therapeutics · doi:10.1002/adtp.202000246 · Cited by 35 · see citing works
Rzymski, P., Pokorska‐Śpiewak, M., Jackowska, T., Kuchar, E. P., Nitsch-Osuch, A. S., Pawłowska, M., Babicki, M., Jaroszewicz, J., Szenborn, L., Wysocki, J., et al. (2023) · Vaccines · doi:10.3390/vaccines11091502 · Cited by 30 · see citing works
Boosting Antitumor Drug Efficacy with Chemically Engineered Multidomain Proteins
Kuan, S. L., Fischer, S., Häfner, S., Wang, T., Syrovets, T., Liu, W., Tokura, Y., Ng, D. Y. W., Riegger, A., Förtsch, C., et al. (2018) · Advanced Science · doi:10.1002/advs.201701036 · Cited by 30 · see citing works
Almeida‐Silva, J., Menezes, D., Fernandes, J. M. P., de Almeida, M. C., Vasco-dos-Santos, D. R., Saraiva, R. M., Viçosa, A. L., Perez, S. A. C., Andrade, S. G., Suarez-Fontes, A. M., et al. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.926699 · Cited by 28 · see citing works
Teicoplanin – Tigecycline Combination Shows Synergy Against Mycobacterium abscessus
Aziz, D. B., Teo, J. W. P., Dartois, V. A., & Dick, T. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.00932 · Cited by 27 · see citing works
Antifungal Drugs: The Current Armamentarium and Development of New Agents
Robbins, N., Wright, G. D., & Cowen, L. E. (2017) · ASM Press eBooks · doi:10.1128/9781555819583.ch44 · Cited by 26 · see citing works
Self-citationTarget identification and assessment in the era of AI
Pun, F. W., Podolskiy, D. I., Izumchenko, E., Mortlock, A. A., Oprea, T. I., Scheibye‐Knudsen, M., Fortney, K., Morgen, E. K., Ren, F., & Zhavoronkov, A. A. (2026) · Nature Reviews Drug Discovery · doi:10.1038/s41573-026-01412-8 · Cited by 28 · see citing works
Synergistic Response of Rifampicin with Hydroperoxides on Mycobacterium: A Mechanistic Study
Patel, Y. S., & Mehra, S. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.02075 · Cited by 22 · see citing works
Tóth, L., Poór, P., Ördög, A., Váradi, G., Farkas, A., Papp, C., Bende, G., Tóth, G. K., Rákhely, G., Marx, F., et al. (2022) · BioControl · doi:10.1007/s10526-022-10132-y · Cited by 21 · see citing works
Further Investigations of Nitroheterocyclic Compounds as Potential Antikinetoplastid Drug Candidates
García‐Estrada, C., Pérez‐Pertejo, Y., Domínguez-Asenjo, B., Holanda, V. N., Murugesan, S., Valladares, M. M., Balaña‐Fouce, R., & Reguera, R. M. (2023) · Biomolecules · doi:10.3390/biom13040637 · Cited by 20 · see citing works
Developing an Agent-Based Drug Model to Investigate the Synergistic Effects of Drug Combinations
Gao, H., Yin, Z., Cao, Z., & Zhang, L. (2017) · Molecules · doi:10.3390/molecules22122209 · Cited by 18 · see citing works
Arockianathan, P. M., Mishra, M., & Niranjan, R. (2019) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026619666190412102037 · Cited by 18 · see citing works
Salama, E. A., Elgammal, Y., Wijeratne, A., Lanman, N. A., Utturkar, S. M., Farhangian, A., Li, J., Meunier, B., Hazbun, T. R., & Seleem, M. N. (2024) · Emerging Microbes & Infections · doi:10.1080/22221751.2024.2322649 · Cited by 16 · see citing works
Kim, S., Woo, J. H., Jun, S. H., Moon, D. C., Lim, S., & Lee, J. C. (2020) · Antibiotics · doi:10.3390/antibiotics9040185 · Cited by 16 · see citing works
Gao, Y., Li, F., Ni, X., Yang, S., Liu, H., Wu, X., Liu, J., & Ma, J. (2023) · RSC Advances · doi:10.1039/d3ra05542f · Cited by 16 · see citing works
da Costa, B. S., Pippi, B., Kaminski, T. F. A., de Andrade, S. F., & Fuentefría, A. M. (2020) · Mycoses · doi:10.1111/myc.13127 · Cited by 16 · see citing works
Maeda, T., Horinouchi, T., Sakata, N., Sakai, A., & Furusawa, C. (2019) · The Journal of Antibiotics · doi:10.1038/s41429-019-0160-5 · Cited by 15 · see citing works
Inhibiting Protein Prenylation with Benzoxaboroles to Target Fungal Plant Pathogens
Kim, S. H., Liu, C., Zhou, Y., Zhang, Y., McGregor, C., Steere, L., Frederick, B. H., Liu, C. T., Whitesell, L. J., & Cowen, L. E. (2020) · ACS Chemical Biology · doi:10.1021/acschembio.0c00290 · Cited by 14 · see citing works
Self-citationRagini, S. P., White, J., Kirby, N. M., Banerjee, R., Bathula, S. R., Drummond, C. J., & Conn, C. E. (2023) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2023.06.122 · Cited by 13 · see citing works
The hidden threat: Unveiling the rise of antifungal drug resistance
Chaudhary, R., & Thakur, Z. (2025) · Microbial Pathogenesis · doi:10.1016/j.micpath.2025.108068 · Cited by 12 · see citing works
Gany, S. S. H. A. E., Azmy, A. F., EL-Gendy, A. O., El-Baky, R. M. A., Mustafa, A., Abourehab, M. A. S., El‐Beeh, M. E., & Ibrahim, R. A. (2024) · International Journal of Microbiology · doi:10.1155/2024/7518368 · Cited by 11 · see citing works
Clorgyline Analogs Synergize with Azoles against Drug Efflux in Candida auris
Toepfer, S., Lackner, M., Keniya, M. V., Zenz, L.-M., Friemert, M., Bracher, F., & Monk, B. C. (2023) · Journal of Fungi · doi:10.3390/jof9060663 · Cited by 10 · see citing works
Curcumin effect on Acanthamoeba triangularis encystation under nutrient starvation
Boonhok, R., Sangkanu, S., Phumjan, S., Jongboonjua, R., Sangnopparat, N., Kwankaew, P., Tedasen, A., Lim, C. L., Pereira, M. D. L., Rahmatullah, M., et al. (2022) · PeerJ · doi:10.7717/peerj.13657 · Cited by 9 · see citing works
Zhang, S., Li, E., Liu, Z., Shang, H., Chen, Y., & Jing, H. (2022) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2022.103731 · Cited by 7 · see citing works
Krátký, M., Konečná, K., Janďourek, O., Diepoltová, A., Vávrová, P., Voxová, B., Vejsová, M., Bárta, P., & Bősze, S. E. (2023) · Microbiology Spectrum · doi:10.1128/spectrum.03064-22 · Cited by 6 · see citing works
A call to arms: Unifying the fight against resistance
Kaushansky, A., Hedstrom, L., Goldman, A. J., Singh, J., Yang, P. L., Rathod, P. K., Cynamon, M. H., Wodarz, D., Mahadevan, D., Tomaras, A. P., et al. (2018) · Science Signaling · doi:10.1126/scisignal.aav0442 · Cited by 6 · see citing works
Wu, Y., Jiang, L., Liu, R., Yang, L., Zou, F., Zhang, T.-Y., Fan, Z., Zhang, T., Yang, H., Yin, S., et al. (2024) · Medicinal Chemistry Research · doi:10.1007/s00044-024-03270-8 · Cited by 5 · see citing works
Inhibition of SARS-CoV-2 Mpro with Vitamin C, L-Arginine and a Vitamin C/L-Arginine Combination
Đukić, I., Kaličanin, N., Senćanski, M., Pajović, S. B., Milićević, J. S., Prljic, J., Paessler, S., Prodanović, R., & Glišić, S. (2023) · Frontiers in Bioscience-Landmark · doi:10.31083/j.fbl2801008 · Cited by 4 · see citing works
Shapiro, R. S., & Gerstein, A. C. (2023) · mBio · doi:10.1128/mbio.01073-23 · Cited by 4 · see citing works
Ježíková, Z., Pagáč, T., Víglaš, J., Pfeiferová, B., Šoltýs, K., Bujdáková, H., Černáková, L., & Olejníková, P. (2019) · Current Microbiology · doi:10.1007/s00284-019-01678-9 · Cited by 4 · see citing works
Dafur, G. S., Kub, T. N. T., Singh, K. K. B., Harun, A. B., Lambuk, F., Mohamud, R., Kadir, R., Ismail, N., & Yusop, N. (2025) · PeerJ · doi:10.7717/peerj.19544 · Cited by 3 · see citing works
Araujo, G. S., de Jesus, I. C. T. A., da Costa, P. C. Q. G., Marques, K. K. G., Gonçalves, J. C. R., & de Castro, R. D. (2026) · Archives of Oral Biology · doi:10.1016/j.archoralbio.2026.106572 · Cited by 3 · see citing works
The Challenge of Resistance in Antimicrobial Drug Development
Anderson, A. C., & Wright, D. L. (2015) · Future Microbiology · doi:10.2217/fmb.15.75 · Cited by 2 · see citing works
Lyras, D., Srikhanta, Y. N., & McGowan, S. (2020) · Nature Microbiology · doi:10.1038/s41564-019-0662-8 · Cited by 2 · see citing works
Jiang, L., Yang, L., Yang, L., Yang, B., Xing, L., Liu, J., Yan, R., Han, J., Li, G., & Wang, R. (2025) · Biochemical Pharmacology · doi:10.1016/j.bcp.2025.117181 · Cited by 1 · see citing works
Sackey, T., Kannan, U., Majumder, S., John, J., Viau, C., Feng, Z., Benoit‐Biancamano, M., Ronholm, J., & George, S. (2026) · The Journal of Antibiotics · doi:10.1038/s41429-026-00903-5 · Cited by 1 · see citing works
Host Immune Responses to Pathogenic Fungi and Contemporary Therapeutic Strategies
Shallal, A. F., Razaq, C. H., Ahmed, A. S., Ahmed, S. S., Eyüpoğlu, V., & Salman, R. S. (2026) · Journal of Mycology and Truffle · doi:10.65999/mycotruffle.2026.26 · Cited by 1 · see citing works
Laboratory Investigations and Result Interpretation
Nedbalcová, K., & Pokludová, L. (2020) · Springer eBooks · doi:10.1007/978-3-030-46721-0_8 · Cited by 1 · see citing works
Functional Genomic and Chemical Biology Analysis of Echinocandin Resistance in Candida albicans
Caplan, T. (2018) · TSpace (University of Toronto) · Cited by 1 · see citing works
Carolus, H., Biriukov, V. V., Vreys, J., Romero, C. L., Avila, J. P. H., Vergauwen, R., Sofras, D., Vanreppelen, G., Vinken, L., Xavier, B. B., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.02.05.636719 · Cited by 1 · see citing works
Targeting Casein Kinases in the Fungal Pathogen Candida albicans
Hyde, S. (2020) · TSpace (University of Toronto)
Odediran, S. A., Ehigie, A. F., Akadiri, S. O., Bamikole, R. A., Adeniyi, R., Adeoti, R., & Aladesanmi, J. A. (2022) · European Journal of Medicinal Plants · doi:10.9734/ejmp/2022/v33i230449
Combinatorial approach to combat drug resistance in human pathogenic fungi
Mir, M. A., Qadri, H., Aisha, S., & Shah, A. H. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-96127-1.00011-5
Translational Research on Chagas Disease: Focusing on Drug Combination and Repositioning
Vannier-Santos, M. A., Suarez-Fontes, A. M., Almeida‐Silva, J., Viçosa, A. L., Perez, S. A. C., Hasslocher‐Moreno, A. M., da Silveira, G. P. E., Portela, L. F., & Saraiva, R. M. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.104231
Криворутченко, Ю. Л., Кirsanova, M. A., Postnikova, O., Andronovskaja, I., & Sheiko, E. (2021) · Immunopathology Allergology Infectology · doi:10.14427/jipai.2021.3.79
Кirsanova, M. A., Криворутченко, Ю. Л., Postnikova, O. N., & Andronovskaia, I. B. (2022) · Antibiot Khimioter = Antibiotics and Chemotherapy · doi:10.37489/0235-2990-2022-67-9-10-25-34
Novel Strategies for Combating Antimicrobial Resistance: Alternative Agents on the Horizon
Navales, I. A. M., Paglas, M. A., Panibon, R., Parcasio, R. D., Parcon, A. B., Pascua, L. L., Patadon, S. O. S., & Padilla, J. (2023) · International Journal of Research Publication and Reviews · doi:10.55248/gengpi.4.1223.123551
Lippia thymoides essential oils activity against Candida species from HIV+ individual oral lesionsPreprint
de Azevedo, F. O., de Oliveira, A. P. R. S., de Farias, A. P. F., Santos, R. P. B., de Oliveira, Y. A., Falcão, M. M. L., Gomes‐Filho, I. S., Angélica, M., Kusterer, L. L., Sarmento, V. A., et al. (2024) · Research Square · doi:10.21203/rs.3.rs-4263276/v1
Udemezue, O. I., Uba, C. C., Udemezue, O. I., Udenweze, E. C., Ezeadila, J. O., & Ezenwelu, C. O. (2024) · International Journal of Biological and Pharmaceutical Sciences Archive · doi:10.53771/ijbpsa.2024.7.2.0040
de Azevedo, F. O., de Oliveira, A. P. R. S., de Farias, A. P. F., Santos, R. P. B., de Oliveira, Y. A., Falcão, M. M. L., Gomes‐Filho, I. S., Lucchese, A. M., Lins-Kusterer, L., Sarmento, V. A., et al. (2025) · Caderno Pedagógico · doi:10.54033/cadpedv22n10-270
Ayala, M., Jakamartana, A., Costa, R. M. D. S., Bednarek, J. M., Moreau, C. T., Cheung, C. K., & Brown, J. C. S. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2025.12.31.697249
Moradpour, F., Javanmardi, S., Omidian, N., Kavyannejad, R., & Mohammadian, M. (2026) · Brain Injury · doi:10.1080/02699052.2026.2616381
Drug combinations: A strategy to extend the life of antimicrobials
Monteiro, K. L. C., Freire, N. M. L., de Aquino, T. M., & Silva-Júnior, E. F. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-36518-8.00003-5
Carolus, H., Biriukov, V. V., Vreys, J., Romero, C. L., Ávila, J. P. H., Vergauwen, R., Sofras, D., Nysten, J. V., Vanreppelen, G., Vinken, L., et al. (2026) · mBio · doi:10.1128/mbio.00588-26
Ayala, M., Jakamartana, A., Costa, R. M. D. S., Cheung, E. C.-K., Bednarek, J. M., Moreau, C. T., & Brown, J. C. S. (2026) · mSphere · doi:10.1128/msphere.00432-26
- Authors
- Hill, J. A., & Cowen, L. E.
- Affiliations
- University of Toronto (CA)
- Venue
- Future Microbiology
- Publisher
- Informa UK Limited
- Published
- 2015-11
- Volume
- 10
- Issue
- 11
- Pages
- 1719-1726
- ISSN
- 1746-0913 (ISSN-L)
- 1746-0921
- OpenAlex
- W2173151789
- Cited by
- 75
- References
- 27
- Citations by year
- 2026: 9 · 2025: 5 · 2024: 5 · 2023: 10 · 2022: 13 · 2021: 3 · 2020: 10 · 2019: 5 · 2018: 6 · 2017: 6 · 2016: 2 · 2015: 1
- FWCI
- 2.07
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Future Microbiology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Ontario Graduate Scholarship
- Canada Research Chair in Microbial Genomics and Infectious Disease
- Ministry of Research and Innovation Early Researcher Award
- Natural Sciences & Engineering Research Council Discovery (355965)
- Canadian Institutes of Health Research (MOP-119520, MOP-86452)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Medicine › Antibiotic Resistance in Bacteria
- Life Sciences › Immunology and Microbiology › Applied Microbiology and Biotechnology › Antibiotic Use and Resistance
- Health Sciences › Medicine › Infectious Diseases › Antimicrobial Resistance in Staphylococcus
- Keywords
- combination therapy, antimicrobial resistance, drug resistance mechanisms, drug interactions
- MeSH terms
- Anti-Infective Agents, Communicable Diseases, Drug Resistance, Drug Therapy, Combination, Humans
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review